rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CLDI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
      Nov 13Yahoo FinanceCLDI
      Calidi Biotherapeutics Addresses NYSE American Compliance Notice

      Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.

      Sep 26The Globe and MailCLDI
      Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
      Sep 25Yahoo FinanceCLDI
      Calidi Biotherapeutics Announces Registered Direct Stock Offering

      Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailCLDI
      Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering

      SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it has entered into a definitive stock purchase agreement with certain accredited investors and/or qualified institutional buyers for the purchase and sale of 1,025,640 shares of the Company’s common stock, in a registered direct offering, at a per share purchase price o

      Sep 17Yahoo FinanceCLDI
      Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

      SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announces that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The conference is being held on September 14 – 16, 2026 at the Lotte New York Palace Hotel. Eric Poma, Ph.D., Chief Executive Officer of Calidi Biotherapeutics will hold one-on-one meetin

      Sep 8Yahoo FinanceCLDI

      This is the newest page. Registered accounts read further back.